As of 2:31 PM on the 7th, Sam-il Pharmaceutical is trading at 22,250 KRW, down 7.87% from the previous day. This represents a 22.25% increase compared to July 13. Sam-il Pharmaceutical is known as a manufacturer and seller of pharmaceuticals and quasi-drugs.
Today, foreigners have net sold 15,000 shares of Sam-il Pharmaceutical, and institutions have net sold 1,000 shares, according to provisional data. Over the past five days, individual investors have net bought 121,511 shares, while foreigners and institutions have net sold 103,268 shares and 12,694 shares, respectively.
On August 6, Sam-il Pharmaceutical became a market issue as it hit the "upper limit price" following news of holding a "NASH treatment drug."
[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
